The most commonly prescribed GLP1 injectable medications in Australia include: Tirzepatide (brand name: Mounjaro KwikPen), which is a dual GIP/GLP1 receptor agonist supplied as a multi-dose pre-filled pen containing four weekly doses per pen
Peri-Meno hates me! Apr 1, 2026 I don't need to lose weight
However, all these treatments are symptomatic and cannot prevent or reverse AD pathology ( Figure 1 ) ( Figure 1 Biological characteristics of GLP-1 In the 1980s, a new glucagon-like peptide, produced from proglucagon cleavage, was discovered to stimulate insulin secretion ( GLP-1, a 36-amino acid peptide, is produced in enteroendocrine L-cells of the distal small bowel and colon ( The effect of GLP-1 depends on blood glucose levels since it can only potentiate glucose-stimulated insulin secretion from islet beta cells in the hyperglycemic state rather than in the normal blood glucose state (98101)
Liraglutide and exenatide were reported to induce apoptosis and autophagy through the AMPK signaling pathway, inhibiting the progression of endometrial cancer (216, 217)
If these side effects become too disruptive, it may be necessary to reconsider the medication regimen